Ipsen and Skyhawk Therapeutics have signed an exclusive worldwide collaboration to discover and develop novel small molecules that modulate RNA for rare neurological diseases.
The...
Ochre Bio has formed a partnership with Boehringer Ingelheim focused on the discovery and development of novel, first-in-class regenerative treatments for chronic liver diseases (CLDs),...
The U.S. Food and Drug Administration (FDA) has approved Takeda's ENTYVIO (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely...